ArticleTherapeutic advances in medical oncology2021

Erdafitinib treatment in Brazilian patients with metastatic urothelial carcinoma (mUC): real-world evidence from an Expanded Access Program.

Fernando Sabino M Monteiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.